MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 66 filers reported holding MERSANA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,406 | -97.8% | 157,800 | -94.2% | 0.00% | -100.0% |
| Q2 2023 | $8,920,210 | -13.1% | 2,711,310 | +8.6% | 0.02% | -22.7% |
| Q1 2023 | $10,261,478 | -30.6% | 2,496,710 | -1.1% | 0.02% | -33.3% |
| Q4 2022 | $14,790,546 | +314.1% | 2,523,984 | +377.6% | 0.03% | +312.5% |
| Q3 2022 | $3,572,000 | +2647.7% | 528,468 | +1517.7% | 0.01% | – |
| Q1 2022 | $130,000 | -96.4% | 32,667 | -91.5% | 0.00% | -100.0% |
| Q3 2021 | $3,628,000 | +1248.7% | 384,736 | +1838.7% | 0.02% | +1400.0% |
| Q2 2021 | $269,000 | -89.1% | 19,845 | -87.0% | 0.00% | -90.9% |
| Q1 2021 | $2,461,000 | -6.6% | 152,110 | +53.5% | 0.01% | -21.4% |
| Q4 2020 | $2,636,000 | +1272.9% | 99,098 | -18.5% | 0.01% | +600.0% |
| Q3 2019 | $192,000 | -72.5% | 121,543 | -29.5% | 0.00% | -66.7% |
| Q2 2019 | $698,000 | +147.5% | 172,381 | +222.3% | 0.01% | +500.0% |
| Q1 2019 | $282,000 | – | 53,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |